You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 262 No. 23, December 15, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Report
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (155)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Determination of Gestational Cocaine Exposure by Hair Analysis

Karen Graham; Gideon Koren, MD; Julia Klein, MSc; Joyce Schneiderman, MD; Mark Greenwald, MD

JAMA. 1989;262(23):3328-3330.


Abstract

Drug self-reports are often unreliable and standard blood and urine tests detect only recent cocaine use. Since cocaine is deposited in hair, we have applied a radioimmunoassay to hair extract to detect past cocaine use. Hair from 16 adult users was positive for benzoylecgonine, in the presence of negative findings from urine screening tests. Benzoylecgonine in admitted heavy users averaged 8775 ng/g of hair (range, 640 to 29 089 ng/g of hair), whereas in occasional users it averaged 624 ng/g of hair (range, 32 to 1210 ng/g of hair). Benzoylecgonine was not detected in hair of 21 adults who reported no use of cocaine ever and whose urine samples were negative for the metabolite. Neonatal hair from seven infants whose mothers were known cocaine users averaged 5430 ng of benzoylecgonine per gram of hair (range, 200 to 27500 ng/g of hair). Hair from two infants 2.5 and 3.5 months of age averaged 6050 ng of benzoylecgonine per gram of hair. However, values were negative for infants 1 year and older, corresponding to loss of fetal hair in the few months after birth. Because studies reporting reproductive risks of cocaine compare exposed and nonexposed groups, validation of drug-free status of control subjects is extremely important. Hair analysis may remedy the disadvantages of currently used methods and may identify intrauterine exposure to cocaine in babies when a maternal drug history is not available or of doubtful truthfulness.

(JAMA. 1989;262:3328-3330)



Author Affiliations

From the Motherisk Program, Division of Clinical Pharmacology and Toxicology, Department of Pediatrics and the Research Institute, The Hospital for Sick Children, Toronto, Canada (Drs Koren, Schneiderman, and Greenwald and Mss Graham and Klein); The University of Toronto, Canada (Dr Koren and Ms Graham); the Addiction Research Foundation, Toronto, Canada (Dr Schneiderman); and York Finch General Hospital, Etobicoke, Canada (Dr Greenwald). Dr Koren is a Career Scientist of the Ontario Ministry of Health.


Footnotes

Presented at the annual meeting of the Society for Pediatric Research, Washington, DC, May 1989.

Reprint requests to Division of Clinical Pharmacology, The Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1x8 (Dr Koren).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Methamphetamine detection in maternal and neonatal hair: implications for fetal safety
Garcia-Bournissen et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2007;92:351-355.
ABSTRACT | FULL TEXT  

Chronic Cocaine Exposure in a Toddler Revealed by Hair Test
Taguchi et al.
CLIN PEDIATR 2007;46:272-275.
 

Hair Analysis for Detection of Psychotropic Drug Use
Mieczkowski
Mayo Clin Proc. 2006;81:568-569.
FULL TEXT  

Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse
Bar-Oz et al.
Arch. Dis. Child. Fetal Neonatal Ed. 2003;88:F98-F100.
ABSTRACT | FULL TEXT  

Relationship between Levels of Indinavir in Hair and Virologic Response to Highly Active Antiretroviral Therapy
Bernard et al.
ANN INTERN MED 2002;137:656-659.
ABSTRACT | FULL TEXT  

Police Drug Testing, Hair Analysis, and the Issue of Race Bias
Mieczkowski et al.
Criminal Justice Review 2002;27:124-140.
ABSTRACT  

m-Hydroxy Benzoylecgonine Recovery in Fetal Guinea Pigs
Iwamoto et al.
Drug Metab. Dispos. 2000;28:335-338.
ABSTRACT | FULL TEXT  

Dose-Response Effect of Fetal Cocaine Exposure on Newborn Neurologic Function
Chiriboga et al.
Pediatrics 1999;103:79-85.
ABSTRACT | FULL TEXT  

Detection of intrauterine illicit drug exposure by newborn drug testing
Kwong and Ryan
Clin. Chem. 1997;43:235-242.
ABSTRACT | FULL TEXT  

The Use of Hair Analysis in a Pretrial Diversion Program in New Orleans
Mieczkowski et al.
Int J Offender Ther Comp Criminol 1995;39:222-241.
ABSTRACT  

Automated Monitoring of Outcomes: Application to Treatment of Drug Abuse
Alemi et al.
Med Decis Making 1994;14:180-187.
ABSTRACT  

Hair Concentrations of Nicotine and Cotinine in Women and Their Newborn Infants
Eliopoulos et al.
JAMA 1994;271:621-623.
ABSTRACT  

Alcohol and Drug Use in the Workplace: Issues, Controversies, and Directions for Future Research
Harris and Heft
Journal of Management 1992;18:239-266.
ABSTRACT  

New Approaches in Drug Testings: A Review of Hair Analysis
MIECZKOWSKI
The ANNALS of the American Academy of Political and Social Science 1992;521:132-150.
ABSTRACT  

Determination of Amitriptyline in the Hair of Psychiatric Patients
Tracqui et al.
Hum Exp Toxicol 1992;11:363-367.
ABSTRACT  

HAIR ANALYSIS FOR DETECTION OF GESTATIONAL COCAINE EXPOSURE
JWatch General 1989;1989:7-7.
FULL TEXT  

Drug Screening in an Unconventional Matrix: Hair Analysis
Bailey
JAMA 1989;262:3331-3331.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.